Sequential CD38 monoclonal antibody retreatment leads to deep remission in a patient with relapsed/refractory multiple myeloma.
Steinhardt MJ, Zhou X, Krummenast F, Meckel K, Nickel K, Böckle D, Messerschmidt J, Knorz S, Dierks A, Heidemeier A, Lapa C, Einsele H, Rasche L, Kortüm KM.
Steinhardt MJ, et al. Among authors: knorz s.
Int J Immunopathol Pharmacol. 2020 Jan-Dec;34:2058738420980258. doi: 10.1177/2058738420980258.
Int J Immunopathol Pharmacol. 2020.
PMID: 33353443
Free PMC article.